Results 331 to 340 of about 117,687 (361)
Some of the next articles are maybe not open access.
Lansoprazole: A Proton Pump Inhibitor
Annals of Pharmacotherapy, 1996OBJECTIVE: To summarize the published data on lansoprazole, a proton pump inhibitor approved by the Food and Drug Administration for use in the treatment of duodenal ulcer, erosive esophagitis, and pathologic hypersecretory conditions (e.g., Zollinger-Ellison syndrome).
openaire +3 more sources
An Overview of Proton Pump Inhibitors
Gastroenterology Nursing, 2003Proton pump inhibitors are the standard of treatment for acid-related disorders. These disorders include gastroesophageal reflux disease and its complications (i.e., erosive esophagitis and Barrett's esophagus), peptic ulcer disease, Zollinger-Ellison syndrome, and idiopathic hypersecretion.
openaire +2 more sources
Deprescribing Proton Pump Inhibitors
JAMA Internal Medicine, 2020Sameer D. Saini +2 more
openaire +2 more sources
Trends in kinase drug discovery: targets, indications and inhibitor design
Nature Reviews Drug Discovery, 2021Misty M Attwood, Stefan Knapp
exaly
Overuse of proton pump inhibitors
Journal of Clinical Pharmacy and Therapeutics, 2008Gregory M. Peterson +2 more
openaire +2 more sources
Proton Pump Inhibitors and Mortality
Gastroenterology, 2023Helge L. Waldum, Reidar Fossmark
openaire +2 more sources